Abstract:Novel therapies for the treatment of familial dilated cardiomyopathy (DCM) are lacking. Shaping research directions to clinical needs is critical. Triggers for the progression of the disorder commonly occur due to specific gene variants that affect the production of sarcomeric/cytoskeletal proteins. Generally, these variants cause a decrease in tension by the myofilaments, resulting in signaling abnormalities within the micro-environment, which over time result in structural and functional maladaptations, leading to heart failure (HF). Current concepts support the hypothesis that the mutant sarcomere proteins induce a causal depression in the tension-time integral (TTI) of linear preparations of cardiac muscle. However, molecular mechanisms underlying tension generation particularly concerning mutant proteins and their impact on sarcomere molecular signaling are currently controversial. Thus, there is a need for clarification as to how mutant proteins affect sarcomere molecular signaling in the etiology and progression of DCM. A main topic in this controversy is the control of the number of tension-generating myosin heads reacting with the thin filament. One line of investigation proposes that this number is determined by changes in the ratio of myosin heads in a sequestered super-relaxed state (SRX) or in a disordered relaxed state (DRX) poised for force generation upon the Ca2+ activation of the thin filament. Contrasting evidence from nanometer–micrometer-scale X-ray diffraction in intact trabeculae indicates that the SRX/DRX states may have a lesser role. Instead, the proposal is that myosin heads are in a basal OFF state in relaxation then transfer to an ON state through a mechano-sensing mechanism induced during early thin filament activation and increasing thick filament strain. Recent evidence about the modulation of these mechanisms by protein phosphorylation has also introduced a need for reconsidering the control of tension. We discuss these mechanisms that lead to different ideas related to how tension is disturbed by levels of mutant sarcomere proteins linked to the expression of gene variants in the complex landscape of DCM. Resolving the various mechanisms and incorporating them into a unified concept is crucial for gaining a comprehensive understanding of DCM. This deeper understanding is not only important for diagnosis and treatment strategies with small molecules, but also for understanding the reciprocal signaling processes that occur between cardiac myocytes and their micro-environment. By unraveling these complexities, we can pave the way for improved therapeutic interventions for managing DCM.

Sarcomeric Protein Isoform Transitions in Cardiac Muscle: a Journey to Heart Failure.

The Impact of Myosin Heavy Chain Isoforms on Contractile Behavior of the Heart

The Curious Role of Sarcomeric Proteins in Control of Diverse Processes in Cardiac Myocytes

Molecular and cellular biology of heart failure

Focus on cardiac troponin complex: From gene expression to cardiomyopathy

Thin filament cardiomyopathies: A review of genetics, disease mechanisms, and emerging therapeutics

Moving beyond simple answers to complex disorders in sarcomeric cardiomyopathies: the role of integrated systems

Titin: The Missing Link in Cardiac Physiology

Titin: roles in cardiac function and diseases

Functional and Molecular Characterisation of Heart Failure Progression in Mice and the Role of Myosin Regulatory Light Chains in the Recovery of Cardiac Muscle Function

Emerging Role For Rbm20 And Its Splicing Substrates In Cardiac Function And Heart Failure

A study of tropomyosin’s role in cardiac function and disease using thin-filament reconstituted myocardium

Mechanical Dysfunction Of The Sarcomere Induced By A Pathogenic Mutation In Troponin T Drives Cellular Adaptation

Genome-wide Translational Reprogramming of Genes Important for Myocyte Functions in Overload-Induced Heart Failure.

Antithetical Regulation of Α-Myosin Heavy Chain Between Fetal and Adult Heart Failure Though Shuttling of HDAC5 Regulating YY-1 Function

Altered Sarco(endo)plasmic Reticulum Calcium Adenosine Triphosphatase 2a Content: Targets for Heart Failure Therapy

Distinct mechanisms drive divergent phenotypes in hypertrophic and dilated cardiomyopathy associated TPM1 variants

Emerging Concepts of Mechanisms Controlling Cardiac Tension: Focus on Familial Dilated Cardiomyopathy (DCM) and Sarcomere-Directed Therapies

Structural and functional mechanisms of actin isoforms

Mutual Potentiation Between Myofibril Assembly and Serum Response Factor in Cardiomyocyte Maturation

CRISPLD1: a novel conserved target in the transition to human heart failure